NCT00658606View on ClinicalTrials.gov

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Plaque Psoriasis
Interventions
DRUG

alefacept

IM

PROCEDURE

Narrow Band UVB Phototherapy

UVB Phototherapy

Trial Locations (12)

T2S 3B3

Calgary

V3R 6A7

Surrey

V5Z 4E8

Vancouver

A1C 2H5

St. John's

N5X 2P1

London

L3P 1A8

Markham

M5S 1B6

Toronto

H2K 4L5

Montreal

H3H 1V4

Montreal

G1J 1X7

Québec

G1V 4X7

Sainte-Foy

S7N 0W8

Saskatoon

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Canada, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00658606 - Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects | Biotech Hunter | Biotech Hunter